This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Bionano (BNGO) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Bionano Genomics (BNGO) is likely to provide updates on earnings and revenues when it reports second-quarter 2021 results.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $5.87, marking a -1.68% move from the previous day.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.72, moving -1.47% from the previous trading session.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $7.15, marking a -1.38% move from the previous day.
Cummins, Century Aluminum, AMC Entertainment, Ashford Hospitality Trust and Bionano Genomics highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cummins, Century Aluminum, AMC Entertainment, Ashford Hospitality Trust and Bionano Genomics highlighted as Zacks Bull and Bear of the Day
These 3 Meme Stocks Aren't as Risky as You May Think
by Shuvra Shankar Dey
Solid revenue and earnings growth prospects of AMC, AHT and BNGO make them relatively safer bets despite being favorites of retail trades on the meme frenzy.
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 0.00% and 13.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Bionano Genomics (BNGO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Bionano Genomics (BNGO) stock based on the movements in the options market lately.
Bionano (BNGO) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Bionano Genomics (BNGO) is expected to provide updates on its earnings and revenues when it reports first-quarter 2021 result.
Bionano Genomics, Inc. (BNGO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session.
Has Bionano Genomics (BNGO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (BNGO) Outperforming Other Medical Stocks This Year?
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $9.38, marking a -1.57% move from the previous day.
Implied Volatility Surging for Bionano Genomics (BNGO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Bionano Genomics (BNGO) stock based on the movements in the options market lately.
Why Bionano Genomics (BNGO) Might Surprise This Earnings Season
by Zacks Equity Research
Bionano Genomics (BNGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading session, marking a +1.13% move from the prior day.
Bionano (BNGO) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Bionano (BNGO) will provide updates on its revenues and earnings when it reports fourth-quarter and full-year 2020 results.
Bionano Genomics, Inc. (BNGO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed at $11.80 in the latest trading session, marking a +1.29% move from the prior day.
Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed at $11.85 in the latest trading session, marking a -1.41% move from the prior day.
New Strong Sell Stocks for October 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's Why
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bionano (BNGO) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Bionano's (BNGO) sales numbers will be in focus when it reports Q2 results later in the week.
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $0.79, moving +0.25% from the previous trading session.
Company News for Jul 13, 2020
by Zacks Equity Research
Companies in the news are: BNGO, AMRX, ALT, EXPR
What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock
by Zacks Equity Research
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).